Ciliatech leadership comments on CE mark for novel glaucoma deviceByHattie Hayes,Kassi FilkinsSeptember 9th 2025
Nicox and Kowa enter commercialisation agreement for NCX 470 glaucoma eye dropByMartin David HarpJuly 23rd 2025
Perfuse Therapeutics shares findings from glaucoma and diabetic retinopathy trials of PER-001BySydney M CragoJuly 9th 2025